The bear case on Eli Lilly has played out, says only firm to have called it a sell

The bear case for Eli Lilly has now played out following the reaction to the drugmaker’s oral obesity drug trial, an analyst said Wednesday in upgrading the stock.

Previous Article

Forget about Fed rate cuts for a second — and worry about how markets are running so low on extra cash

Next Article

Zelensky Threatens 'Future Of Friendship Depends On Hungary's Stance' After Kiev Attacks Key Pipeline Again

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

Subscribe to our Newsletter

Subscribe to our email newsletter to get the latest posts delivered right to your email.
Pure inspiration, zero spam ✨